Publications | UCSF Philip R. Lee Institute for Health Policy Studies

The Triple Bottom Line and Stabilization Wedges: A Framework for Perioperative Sustainability.

By: Choi BJJ, Chen CL

Anesth Analg 2022 Mar doi: 10.1213/ANE.0000000000005890

Multicancer Screening Tests: Anticipating And Addressing Considerations For Payer Coverage And Patient Access.

Deverka PA, Douglas MP, Phillips KA

Health Aff (Millwood) 2022 Mar doi: 10.1377/hlthaff.2021.01316

Breast biopsy patterns and findings among older women undergoing screening mammography: The role of age and comorbidity.

Advani S, Abraham L, Buist DSM, Kerlikowske K, Miglioretti DL, Sprague BL, Henderson LM, Onega T, Schousboe JT, Demb J, Zhang D, Walter LC, Lee CI, Braithwaite D, O'Meara ES, Breast Cancer Surveillance Consortium.

J Geriatr Oncol 2022 Mar doi: 10.1016/j.jgo.2021.11.013

Improving Health Care Transitions for Children and Youth With Special Health Care Needs.

Okumura MJ, Kuo DZ, Ware AN, Cyr MH, White PH

Acad Pediatr 2022 Mar doi: 10.1016/j.acap.2021.03.014

Characterization of Internal Medicine Chief Resident Administrative, Educational, and Clinical Experiences.

Garg M, Kompala T, Hurley M, López L

JAMA Netw Open 2022 Mar doi: 10.1001/jamanetworkopen.2022.3882

Diagnostic reference levels and median doses for common clinical indications of CT: findings from an international registry.

Bos D, Yu S, Luong J, Chu P, Wang Y, Einstein AJ, Starkey J, Delman BN, Duong PT, Das M, Schindera S, Goode AR, MacLeod F, Wetter A, Neill R, Lee RK, Roehm J, Seibert JA, Cervantes LF, Kasraie N, Pike P, Pahwa A, Jeukens CRLPN, Smith-Bindman R

Eur Radiol 2022 Mar doi: 10.1007/s00330-021-08266-1

Review of publications evaluating opioid use in patients with inflammatory rheumatic disease.

Anastasiou C, Yazdany J

Curr Opin Rheumatol 2022 Mar doi: 10.1097/BOR.0000000000000868

The Opportunity to End Child Marriage Throughout the World.

Irwin CE Jr

J Adolesc Health 2022 Mar doi: 10.1016/j.jadohealth.2021.12.007

Cost-Effectiveness and Value-Based Pricing of Aducanumab for Patients With Early Alzheimer Disease.

Whittington MD, Campbell JD, Rind D, Fluetsch N, Lin GA, Pearson SD

Neurology 2022 Mar doi: 10.1212/WNL.0000000000013314

The Costs and Health Benefits of Expanded Access to MDMA-assisted Therapy for Chronic and Severe PTSD in the USA: A Modeling Study.

Avanceña ALV, Kahn JG, Marseille E

Clin Drug Investig 2022 Mar doi: 10.1007/s40261-022-01122-0